Dual GLP-1/GIP Agonists (e.g. Tirzepatide): From Theory to Practice – 1 CME Point
Speaker
Mr. Yousaf Ahmad
Pharmaceutical Expert
If you register now, then you can choose to watch it live or later. The webinar will be available later, but without any CME points.
>LIVE: 5 Decemeber 2026 10:00 am (UK time zone)
Agenda
- 40 minutes presentation and then 20 minutes Q&A with the host Nathan Nagel
-
Overview of dual GLP‑1/GIP receptor pharmacology
-
Comparative efficacy in weight and glycaemic control
-
Patient selection beyond traditional GLP‑1 therapies
-
Managing gastrointestinal and metabolic side effects
-
Practical steps for primary care integration
-
Addressing access and equity in obesity pharmacotherapy
Upcoming Lectures
8:00 pm Tuesday 19th Jan 2027
Lecture
Building Compassionate Obesity Services: A Mental Health First Approach – 1 CME Point
8:00 pm Tuesday 8th Dec 2026
Lecture
Pharmacotherapy, Psychology, and Weight Loss: Supporting the Whole Patient – 1 CME Point
8:00 pm Tuesday 27th Oct 2026